IRIS
D'ANDREA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.928
AS - Asia 996
EU - Europa 848
SA - Sud America 152
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 27
OC - Oceania 5
Totale 4.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.822
SG - Singapore 482
IT - Italia 398
CN - Cina 200
VN - Vietnam 138
BR - Brasile 113
DE - Germania 106
RU - Federazione Russa 89
BD - Bangladesh 57
CA - Canada 53
IE - Irlanda 48
GB - Regno Unito 40
SE - Svezia 33
FI - Finlandia 31
HK - Hong Kong 31
MX - Messico 22
NL - Olanda 21
FR - Francia 19
IN - India 19
LT - Lituania 17
TR - Turchia 17
AR - Argentina 13
ES - Italia 11
AT - Austria 10
PL - Polonia 10
ZA - Sudafrica 10
JP - Giappone 9
CO - Colombia 8
ID - Indonesia 8
EC - Ecuador 7
IQ - Iraq 7
CR - Costa Rica 6
KR - Corea 6
AU - Australia 5
JM - Giamaica 5
BE - Belgio 4
EE - Estonia 4
EG - Egitto 4
HN - Honduras 4
PK - Pakistan 4
TT - Trinidad e Tobago 4
CL - Cile 3
KE - Kenya 3
TH - Thailandia 3
VE - Venezuela 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
GP - Guadalupe 2
GT - Guatemala 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
SV - El Salvador 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AW - Aruba 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
IL - Israele 1
JO - Giordania 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
TZ - Tanzania 1
UA - Ucraina 1
UY - Uruguay 1
Totale 3.957
Salva come PNG Salva come JPEG
Città #
Singapore 386
San Jose 306
Ashburn 157
Council Bluffs 103
Munich 70
Dallas 67
Los Angeles 67
Beijing 55
Santa Clara 50
The Dalles 50
Dublin 46
Ho Chi Minh City 46
Chandler 43
Rome 42
Milan 40
New York 37
North Bergen 33
Buffalo 32
Hong Kong 28
Phoenix 26
Chicago 25
Pescara 25
Denver 24
Hanoi 22
Orem 20
Hefei 17
Tongling 16
Brooklyn 15
Silvi 15
Columbus 14
Frankfurt am Main 14
São Paulo 14
Redondo Beach 13
Lappeenranta 12
Montreal 12
Princeton 12
Toronto 12
Turku 12
Chieti 11
Nuremberg 11
Atlanta 10
Düsseldorf 10
Moscow 10
Vilnius 10
Da Nang 9
Stockholm 9
Turin 9
Warsaw 9
Washington 9
Houston 8
Teramo 8
Tokyo 8
Amsterdam 7
Ankara 7
Bologna 7
Boston 7
Helsinki 7
Querétaro 7
Seattle 7
Xi'an 7
Bari 6
Camerino 6
Florence 6
Haiphong 6
Manchester 6
Reggio Emilia 6
Seoul 6
Verona 6
Bogotá 5
Brasília 5
Castignano 5
Chennai 5
Irsina 5
Istanbul 5
Johannesburg 5
League City 5
Mumbai 5
Naples 5
Ninh Bình 5
San Francisco 5
Altamura 4
Augusta 4
Baghdad 4
Boardman 4
Brussels 4
Can Tho 4
Charleston 4
Elk Grove Village 4
Guangzhou 4
Kingston 4
Mexico City 4
Ottawa 4
Philadelphia 4
San José 4
San Potito Sannitico 4
Agrolândia 3
Ancona 3
Brescia 3
Cagliari 3
Cairo 3
Totale 2.348
Salva come PNG Salva come JPEG
Nome #
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 203
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study 197
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 157
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression 143
Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder: Clinical and biological correlates 134
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project) 130
Addiction biotypes: a paradigm shift for future treatment strategies? 125
Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder 120
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 118
From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder 118
Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review 117
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 116
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 116
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder 115
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 113
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 110
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder 109
Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization 108
Combining Dopamine Agonists With Accelerated Repetitive Transcranial Magnetic Stimulation: A Case of Successful Treatment of Resistant Depression 107
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 106
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 105
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 105
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 103
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 100
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience) 100
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 98
Language proficiency and mental disorders among migrants: A systematic review 87
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes 76
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia 72
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 70
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions 69
Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)] 68
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 66
The transition time to gambling disorder: The roles that age, gambling preference and personality traits play 64
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group 56
Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group 49
Linking Striatal Dopaminergic Asymmetry with Personality Traits: Insights from Gambling Disorder 48
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties? 43
Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression 37
null 22
Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study 19
Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole 13
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World Study 12
Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care 11
Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study 11
Prefrontal transcranial direct current stimulation in alcohol use disorder: a pilot randomized sham-controlled trial with exploratory effects on reward craving and depressive symptoms 4
Totale 4.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202222 0 0 0 0 1 0 0 3 4 2 2 10
2022/2023150 7 18 10 5 18 25 8 14 32 4 2 7
2023/2024311 10 19 35 16 37 44 37 29 18 16 15 35
2024/2025751 50 107 68 49 41 23 53 29 48 67 118 98
2025/20261.980 177 65 129 244 221 99 225 163 198 151 203 105
2026/2027834 50 172 193 317 102 0 0 0 0 0 0 0
Totale 4.070